Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The normal human prostate does not significantly affect blood DHT levels.

Finasteride and low-dose dutasteride combo improves hair growth and reduces hair loss with no major side effects.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

Finasteride use may cause sexual dysfunction; more research needed.

Transcutol P best increases Finasteride absorption for hair loss treatment.

Accurate method measures finasteride levels in human plasma using gas chromatography-mass spectrometry.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Gene mutations can cause problems in male genital development.

Finasteride effectively treats baldness but may cause sexual side effects.

Finasteride may cause slight depression and anxiety.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Men with enlarged prostates often have more severe baldness.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.